🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an efficacy and safety study to compare aprepitant with ondansetron...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-12
Trial ID
NCT01636947
The purpose of this study was to determine the appropriate dosing regimen o...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-13
Trial ID
NCT01697579
Treatments Being Tested
Olanzapine is frequently used off-label as an adjunct antiemetic in clinica...
Status
Completed
Location
Hôpital Charles-LeMoyne
Start Date
2019-04-29
Trial ID
NCT04075955
Treatments Being Tested
This study will compare the relative bioavailability of both an oral capsul...
Status
Completed
Location
Quotient Sciences Limited
Start Date
2019-03-20
Trial ID
NCT03889366
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of a 3...
Status
Completed
Location
Phoenix Childrens Hospital ( Site 1101)
Start Date
2019-09-09
Trial ID
NCT04054193
Treatments Being Tested
This study will assess the efficacy of a single dose of intravenous (IV) fo...
Status
Terminated
Location
Multiple Locations
Start Date
2011-10-25
Trial ID
NCT01405924
Treatments Being Tested
This study will compare the safety and efficacy of a three-day oral aprepit...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-13
Trial ID
NCT01362530
RATIONALE: Aprepitant, palonosetron, and dexamethasone may help lessen or p...
Status
Completed
Location
St. Josephs/Cander Hospital
Start Date
2006-06
Trial ID
NCT00381862
Delayed nausea is a common problem after high dose chemotherapy for bone ma...
Status
Completed
Location
Uppsala University Hospital
Start Date
2010-05
Trial ID
NCT01101529
Treatments Being Tested
RATIONALE: Antiemetic drugs, such as aprepitant, granisetron, and dexametha...
Status
Completed
Location
Barbara Ann Karmanos Cancer Institute
Start Date
2004-10
Trial ID
NCT00293384
Treatments Being Tested